Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.
Tony Hagen, Senior Editor, The Center for Biosimilars
Advertisement
Articles by Tony Hagen, Senior Editor, The Center for Biosimilars
Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months
CROs are also adapting to pandemic.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
2
Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans
3
Vitiligo is associated with mental heath conditions, other autoimmune diseases
4
Make lab monitoring of patents taking isotretinoin less routine, more based on symptoms
5